Summary
Metabolic dysfunction-associated steatotic liver disease (MASLD), the condition formerly known as non-alcoholic fatty liver disease (NAFLD), reflects the pathophysiology of the condition without the use of potentially stigmatizing terms. Learn about the evaluation of and screening for MASLD, as well as emerging treatments.
Featured Authors
Kathleen Dungan, MD, MPH
The Ohio State University
Deborah Gordish, MD
The Ohio State University